Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tong Min Kim

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Diabetes & Metabolism Journal|May 21, 2020
Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World EvidenceJeongmin Lee, Tong Min Kim, Hyunah Kim, et al.
Basic & Clinical Pharmacology & Toxicology|November 26, 2019
The short-term effects of angiotensin II receptor blockers on albuminuria and renal function in Korean patientsJuyoung Shin, Hun-Sung Kim, Tong Min Kim, et al.
Frontiers of Medicine|November 29, 2018
Long-term effects of various types of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on changes in glomerular filtration rate in KoreaSeo Yeon Baik, Hyunah Kim, So Jung Yang, et al.
Endocrinology and Metabolism (Seoul, Korea)|March 4, 2017
Development of Clinical Data Mart of HMG-CoA Reductase Inhibitor for Varied Clinical ResearchHun Sung Kim, Hyunah Kim, Yoo Jin Jeong, et al.
Basic & Clinical Pharmacology & Toxicology|July 14, 2018
Clinical experiences and case review of angiotensin II receptor blocker-related angioedema in KoreaHyunah Kim, Seo Yeon Baik, So Jung Yang, et al.
Applied Clinical Informatics|September 29, 2016
Social Networking Services-Based Communicative Care for Patients with Diabetes Mellitus in KoreaHun-Sung Kim, Yoo Jin Jeong, Sun Jung Baik, et al.
Cardiovascular Therapeutics|February 22, 2018
Change in ALT levels after administration of HMG-CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practiceHyunah Kim, Hyeseon Lee, Tong Min Kim, et al.
Pharmacoepidemiology and Drug Safety|May 31, 2017
The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG-CoA reductase inhibitors prescribed in Korean patientsTong Min Kim, Hyunah Kim, Yoo Jin Jeong, et al.
Basic & Clinical Pharmacology & Toxicology|February 7, 2017
Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in KoreansHun-Sung Kim, Hyeseon Lee, Sue Hyun Lee, et al.
Diabetes & Metabolism Journal|May 25, 2017
Physician-Directed Diabetes Education without a Medication Change and Associated Patient OutcomesHun Sung Kim, Hyunah Kim, Hae Kyung Yang, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Diabetes & Metabolism Journal|May 21, 2020
Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World EvidenceJeongmin Lee, Tong Min Kim, Hyunah Kim, et al.
Basic & Clinical Pharmacology & Toxicology|November 26, 2019
The short-term effects of angiotensin II receptor blockers on albuminuria and renal function in Korean patientsJuyoung Shin, Hun-Sung Kim, Tong Min Kim, et al.
Frontiers of Medicine|November 29, 2018
Long-term effects of various types of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on changes in glomerular filtration rate in KoreaSeo Yeon Baik, Hyunah Kim, So Jung Yang, et al.
Endocrinology and Metabolism (Seoul, Korea)|March 4, 2017
Development of Clinical Data Mart of HMG-CoA Reductase Inhibitor for Varied Clinical ResearchHun Sung Kim, Hyunah Kim, Yoo Jin Jeong, et al.
Basic & Clinical Pharmacology & Toxicology|July 14, 2018
Clinical experiences and case review of angiotensin II receptor blocker-related angioedema in KoreaHyunah Kim, Seo Yeon Baik, So Jung Yang, et al.
Applied Clinical Informatics|September 29, 2016
Social Networking Services-Based Communicative Care for Patients with Diabetes Mellitus in KoreaHun-Sung Kim, Yoo Jin Jeong, Sun Jung Baik, et al.
Cardiovascular Therapeutics|February 22, 2018
Change in ALT levels after administration of HMG-CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practiceHyunah Kim, Hyeseon Lee, Tong Min Kim, et al.
Pharmacoepidemiology and Drug Safety|May 31, 2017
The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG-CoA reductase inhibitors prescribed in Korean patientsTong Min Kim, Hyunah Kim, Yoo Jin Jeong, et al.
Basic & Clinical Pharmacology & Toxicology|February 7, 2017
Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in KoreansHun-Sung Kim, Hyeseon Lee, Sue Hyun Lee, et al.
Diabetes & Metabolism Journal|May 25, 2017
Physician-Directed Diabetes Education without a Medication Change and Associated Patient OutcomesHun Sung Kim, Hyunah Kim, Hae Kyung Yang, et al.
Pageof 3